Nomenclature
In this publication the one letter amino acid abbreviation is used. Correspondingly, D P = D-Proline, G = Glycine, A = Alanine, S = Serine, X = L-(+)-2-aminobutyric acid (Abu), V = Valine, N = Aspargine, Q = Glutamine. Throughout the paper alfa ( ), beta ( ), gamma ( ), delta ( ) and epsilon ( ) notations are given for side chain positions. For notation of amide protons of the peptide bonds the letter N is used, i.e. V10 designates the beta-proton of Valine 10, and A3N the amide proton of Alanine 3. Figure S1. The structure of the investigated cyclic -hairpins with the amino acids given with the one letter acronyms used. Here, R = OH for peptide 1 and R = CH 3 for peptide 2.
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Experimental section
2.1 Synthesis. The synthetic protocol is outlined in Scheme S1. All reagents and solvents were obtained from commercial sources and were used without further purification. Fmoc-protected amino acids and O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TBTU) were purchased from AAPPTec. Dimethylformamide (DMF, analytical grade, 99.8%) was obtained from VWR, piperidine (99%) from Acros Organics, O-(7-azabenzotriazol-1-yl)-N,N,N ,N -tetramethyluronium hexafluorophosphate (HATU) and diisopropylethylamine (DIPEA, 99%) from Sigma Aldrich. Alanine substituted 2-chlorotritylchloride resin (loading rate 0,87 mmol g -1 ) was purchased from RAPP Polymere.
Solid phase peptide synthesis was carried out following the standard Fmoc-protecting scheme on 2-chlorotritylchloride resin on 0.4 mmol scale using a PS3 Peptide Synthesizer (Protein Technologies Inc). Trityl (N, G) and tert-butyl (S) groups were used for side chain protection. Coupling reactions were performed in DMF (3 mL/coupling) using DIPEA as base (0.4 M, 3 mL/coupling) and TBTU (0.48 mmol) as coupling reagent. Double couplings (2x 50 min) were used for all steps followed by capping with 20% acetic anhydride in DMF (5 mL) for 20 min. Fmoc-deprotection was performed with 20% piperidine in DMF (5 mL/coupling). Following completion of the synthesis of the linear peptide the resin was transferred to a disposable syringe fitted with a porous polypropylene frit and was washed at least five times with dichloromethane (DCM), dried in a steam of nitrogen gas and under vacuum and was then stored at -18 ºC.
The resin was swelled in DCM for 30 min and the linear peptide was then cleaved by treatment with 1% trifluoroacetic acid in DCM for 2x 1 h, using a tube rotator. The resin was filtered off and washed with DCM. The combined filtrates were concentrated and the product was precipitated with hexane from a DCM solution (15 mL hexane per 1 mL DCM solution). The mixture was placed in the fridge over night to allow full precipitation. The crude peptide was collected as a white precipitate by centrifugation and was subsequently cyclized. The linear peptide (ca 0.2 mmol) dissolved in DMF (52 mL), and HATU (1.5 eq.) dissolved in DMF (52 mL) were added dropwise to a stirred solution of DIPEA (6 eq) and HATU (1.5 eq) in DMF (104 mL) over 6 h, yielding a final 10 -3 M peptide concentration. The reaction was stirred at room temperature overnight followed by evaporation of the solvent and the base. The crude was dissolved in DCM and the product was precipitated with hexane (15 mL hexane per 1 mL DCM solution). The crude peptide was collected by centrifugation and was then dissolved in 95% TFA in H 2 O (5.8 mL) for removal of all side chain protecting groups. Triisopropylsilane (0.4 mL) was added and the reaction mixture was stirred at room temperature for 2 h. For purification, the crude peptide was dissolved in acetonitrile/0.1% aqueous formic acid (1/9), filtered through a PTFE membrane and purified by RP-HPLC on a LaPrep preparative HPLC using a Gemini C18 column (10μm, 250 x 21.2 mm, Phenomenex). Acetonitrile and 0.1% aqueous formic acid were used as mobile phases with a gradient of 10-95% acetonitrile over 30 min at a flow rate of 20 mL/min and UV detection at 220 nm. The fractions were analyzed by LCMS (API SCIEX 150 EX Perkin Elmer ESI-MS (30 eV) fitted with a Perkin Elmer gradient pump system and a C8 column (Gemini) using acetonitrile and 1% formic acid in water as mobile phases with a gradient of 5 to 95% acetonitrile over 4 min. The identity of the products was confirmed by NMR using Agilent 400 MHz and 500 MHz spectrometers.
Molecular graphics and analyses were performed with the UCSF Chimera package (http://www.cgl.ucsf.edu/ chimera/). Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311). denotes the interproton distance between proton A and B, and AB the cross-relaxation rate between the two spins. The geminal methylene protons (1.78 Å) of G7 were used as distance reference (r ref ), whereas those of S4 and G2 for confirmation of the derived distances. For each distance restraint at least 3 mixing times giving a linear (r 2 >0.9) NOE build up were used to estimate the buildup rate ( AB ). All cross peaks and diagonal peaks were integrated and peak areas were normalized according to ((cross peak 1 x cross peak 2) / (diagonal peak 1 x diagonal peak 2)) 0.5
.
Calculated distances are shown in Table S3 and S4, for peptides 1 and 2, respectively. Figure S2 . Build-up curves for interproton distances of peptide 1. Figure S4 . Chemical shift melting curves for various CH protons of peptide 1, determined with SigmaPlot. Figure S5 . Chemical shift melting curves for various CH protons of peptide 2, determined with SigmaPlot.
Supporting Information
S8
Supporting Information
S13
Supporting Information
S14
Computational conformational analysis
Restraint-free conformational searches were performed by the Monte Carlo algorithm (intermediate torsion sampling) followed by Molecular Mechanics energy minimization steps using the OPLS-2005 force field and water solvent model, as implemented in the software Macromodel 9.3.5 (Schrödinger Inc.). 6 This force field provided high quality stretch, bend and torsion parameters for the investigated peptides. For each peptide 50000 Monte Carlo steps followed by a maximum of 5000 energy minimization steps were run using the Polak-Ribiere type conjugate gradient (PRCG) algorithm with the RMSD cutoff of 2.0 Å. All conformations within 42 kJ mol -1 from the global minimum converged and were retained.
For peptide 1, 451 unique conformations were found and were energy minimized with good convergence. 17 conformations were found within 3.00 kcal/mol (12.55 kJ/mol) of the global minimum and 451 conformations within 10.00 kcal/mol (41.84 kJ/mol) of the global minimum. The first seven conformations were found on an average 30 times.
For peptide 2, 223 unique conformations were found and were energy minimized with good convergence. 9 conformations were found within 3.00 kcal/mol (12.55 kJ/mol) of the global minimum and 222 conformations within 10.00 kcal/mol (41.84 kJ/mol) of the global minimum. The first seven conformations were found on an average 8 times.
For subsequent ensemble calculations, using NAMFIS and DISCON, these conformational pools were reduced to the essential conformational families using the redundant conformer elimination algorithm of MacroModel using the RMSD cutoff 3 Å, which yielded 43 and 40 unique conformations for peptides 1 and 2, respectively.
Ensemble analysis using the software NAMFIS and DISCON
NAMFIS and DISCON analysis:
Ensemble calculations were performed by fitting the experimentally measured distances to the computationally predicted conformations, following previously described protocols.
Results obtained with the software NAMFIS were reproduced using DISCON, a recently developed windowsbased software (http://discon.sourceforge.net/). For the NAMFIS analysis dihedral angles were calculated from the experimentally detected coupling constants using the Karplus equation developed specifically for peptides. figure S5 (peptide 1) and S6 (peptide 2).
b Conformation 2 and 3 of peptide 1 gives a total of 88% folded -hairpin solution conformation .
c Conformation 2 of peptide 2 gives a total of 55% folded -hairpin solution conformation. Figure S6 . Conformers of peptide 1, as selected by NAMFIS-analysis. Hydrogen bonds are indicated with green dotted lines and aliphatic protons are omitted for clarity. The major conformations (Table S11) are shown: conformation 2 (top left), conformation 3 (top right), conformation 1 (bottom left) and overlay of conformation 2 (green) and 3 (black, bottom right) differing mainly in the orientation of the S4-S9 region. Thus, in conformation 3 the side chains are pointing inwards leading to a hydrogen bond whereas in conformation 2 these side chains are pointing outwards. Based on the experimental data conclusion can only be drawn regarding the population of the folded -hairpin versus the unfolded conformations, i.e. the analysis does not provide direct information on of the relative orientation of the S4-S9 side chains.
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Figure S7. Conformers of peptide 2, as selected by NAMFIS-analysis. The major conformations (Table S11) are shown: conformation 2 (top left), conformation 3 (top right), conformation 5 (bottom left) and conformation 6 (bottom left). Hydrogen bonds are indicated with green dotted lines and aliphatic protons are omitted for clarity.
DISCON
Following the recommendations in the DISCON manual the following settings were used for ensemble analysis:
Number of conformations to fit: 10 Parameters: Use all parameters, NOE weight= 1.0, couple weight= 0. Figure S6. b See Figure S7 . 
